Trial record 1 of 1 for:
M20-124 | Recruiting, Not yet recruiting Studies
First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanced Or Metastatic Tumors
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04417465 |
|
Recruitment Status :
Recruiting
First Posted : June 4, 2020
Last Update Posted : December 7, 2023
|
Sponsor:
Calico Life Sciences LLC
Collaborator:
AbbVie
Information provided by (Responsible Party):
Calico Life Sciences LLC
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | August 29, 2025 |
| Estimated Study Completion Date : | April 30, 2026 |